GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients. 2017

Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
a Department of Obstetrics and Gynecology , Otto-von-Guericke University , Magdeburg , Germany.

Recently, we found that G-protein-coupled estrogen receptor (GPER) protein expression decreased during breast carcinogenesis, and that GPER promoter is methylated. Here we analyzed GPER promoter methylation in 260 primary breast cancer specimens by methylation-specific polymerized chain reaction. The results demonstrated that GPER protein down-regulation significantly correlated with GPER promoter hypermethylation (p < .001). Comparison of 108 tumors and matched normal breast tissues indicated a significant GPER down-regulation in cancer tissues correlating with GPER promoter hypermethylation (p < .001). The latter was an unfavorable factor for overall survival of patients with triple-negative breast cancer (p = .025). Thus GPER promoter hypermethylation might be used as a prognostic factor.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
January 2004, Breast cancer research : BCR,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
September 2004, Revista medica de Chile,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
June 2013, Translational oncology,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
April 2012, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
June 2013, Cancer investigation,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
June 2012, Cancer epidemiology,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
February 2019, Journal of cellular physiology,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
July 2020, Neoplasma,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
June 2011, Clinical cancer research : an official journal of the American Association for Cancer Research,
Christine Weissenborn, and Tanja Ignatov, and Norbert Nass, and Thomas Kalinski, and Serban Dan Costa, and Ana Claudia Zenclussen, and Atanas Ignatov
April 2015, Oncology letters,
Copied contents to your clipboard!